GREENVILLE, Wis., May 02, 2017 -- School Specialty, Inc. (OTCQB:SCOO) (“School Specialty”, “SSI” or “the Company”), a leading distributor of supplies, furniture and both curriculum and supplemental learning resources to the education, healthcare and other marketplaces, today announced that it will be reporting its financial results for its fiscal 2017 first quarter ended April 1, 2017 on Tuesday, May 9, 2017.
The Company further disclosed that it will be hosting a teleconference and webcast on Thursday, May 11, 2017 at 9:00 a.m. Eastern to discuss its results and outlook. Speaking from management will be Joseph M. Yorio, President and Chief Executive Officer and Ryan M. Bohr, Executive Vice President and Chief Financial Officer.
Conference Call Information:
- Toll-free number: 844-882-7832 / International number: 574-990-9706 / Conference ID: 17253649
Interested parties can also participate on the webcast by visiting the Investor Relations section of School Specialty’s website at http://investors.schoolspecialty.com. For those who are unable to participate on the live conference call and webcast, a replay will be available approximately one hour after the completion of the call.
Replay Information
- Replay number: 855-859-2056 / International replay number: 404-537-3406 / Conference ID: 17253649
About School Specialty, Inc.
School Specialty is a leading distributor of innovative and proprietary products, programs and services to the education marketplace. The Company designs, develops, and provides educators with the latest and very best school supplies, furniture and both curriculum and supplemental learning resources. Working in collaboration with educators, School Specialty reaches beyond the scope of textbooks to help teachers, guidance counselors and school administrators ensure that every student reaches his or her full potential. Through its SSI Guardian subsidiary, the Company is also committed to school, healthcare and corporate workplace safety by offering the highest quality curriculum, training and safety and security products. Through its recently launched SOAR Life Products brand, the Company offers thousands of products that sharpen cognitive skills and build physical and mental strength in fun and creative ways. From childhood through adulthood, they help individuals live life to the fullest – engaged, happy and well. SOAR Life Products is a customized offering for hospitals, long-term care, therapeutic facilities, home care, surgery centers, day care centers, physician offices, and clinics. For more information about School Specialty, visit www.schoolspecialty.com.
Company Contact Ryan M. Bohr [email protected] Tel: 920-882-5868 Investor and Media Relations Contact Glenn Wiener [email protected] Tel: 212-786-6011


Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales 



